莫西沙星未能预防接受外周血干细胞移植的中性粒细胞减少患者发生对环丙沙星和左氧氟沙星敏感的铜绿假单胞菌菌血症，此为明显的治疗失败。 - Suppr | 超能文献

Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.

作者信息

Prabhu Rajesh M, Elliott Michelle A, Patel Robin

出版信息

Clin Infect Dis. 2004 Apr 1;38(7):1043-5. doi: 10.1086/382706.

DOI:10.1086/382706

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.莫西沙星未能预防接受外周血干细胞移植的中性粒细胞减少患者发生对环丙沙星和左氧氟沙星敏感的铜绿假单胞菌菌血症，此为明显的治疗失败。

Clin Infect Dis. 2004 Apr 1;38(7):1043-5. doi: 10.1086/382706.

2

Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.使用新型氟喹诺酮类药物普卢利沙星根除铜绿假单胞菌所致严重感染的微生物学理论依据。

Int J Antimicrob Agents. 2005 Nov;26(5):366-72. doi: 10.1016/j.ijantimicag.2005.07.015. Epub 2005 Oct 7.

3

Moxifloxacin prophylaxis in neutropenic patients.莫西沙星用于中性粒细胞减少患者的预防治疗。

J Antimicrob Chemother. 2006 Oct;58(4):891-4. doi: 10.1093/jac/dkl320. Epub 2006 Jul 30.

4

An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.左氧氟沙星和环丙沙星对铜绿假单胞菌临床分离株的体外研究。

Int J Antimicrob Agents. 2007 Oct;30(4):374-6. doi: 10.1016/j.ijantimicag.2007.06.003. Epub 2007 Jul 30.

5

Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.左氧氟沙星-亚胺培南联合用药可防止铜绿假单胞菌临床分离株产生耐药性。

Clin Infect Dis. 2005 Feb 15;40 Suppl 2:S105-14. doi: 10.1086/426190.

6

In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.在脓毒症小鼠模型中，采用全或无死亡率终点指标测定吉米沙星、莫西沙星和左氧氟沙星对携带gyrA和parC点突变肺炎球菌的体内活性。

Int J Antimicrob Agents. 2005 Feb;25(2):163-7. doi: 10.1016/j.ijantimicag.2004.08.017.

7

Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.左氧氟沙星与莫西沙星体外抗菌效果及角膜上皮毒性比较

Cornea. 2007 Jul;26(6):720-5. doi: 10.1097/ICO.0b013e3180515251.

8

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.在接受左氧氟沙星预防治疗的中性粒细胞减少患者中，由草绿色链球菌引起的菌血症对左氧氟沙星的敏感性降低。

Clin Infect Dis. 2002 Jun 1;34(11):1469-74. doi: 10.1086/340352. Epub 2002 May 7.

9

In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.美罗培南与环丙沙星联合对铜绿假单胞菌临床分离株的体外活性

Int J Antimicrob Agents. 2005 Feb;25(2):181-2. doi: 10.1016/j.ijantimicag.2004.11.005.

10

Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.

J Chemother. 2004 Apr;16 Suppl 2:3-7. doi: 10.1080/1120009x.2004.11782365.

引用本文的文献

1

Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.莫西沙星不改变移植患者中环孢素的药代动力学：一项多剂量、非对照、单中心研究。

Clin Drug Investig. 2010;30(5):279-87. doi: 10.1007/BF03256904.

2

Prophylactic application of fluoroquinolones for selective decontamination of the gut: friend or foe.氟喹诺酮类药物预防性应用于肠道选择性去污：是福是祸。

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):109-10. doi: 10.1007/s10096-005-1282-1.